Perindopril, Amlodipine, and Indapamide combination significantly lowers Blood Pressure: Brisighella Heart Study Dr. Prem Aggarwal28 April 2022 12:45 PM ISTItaly: Triple combination of perindopril/amlodipine/indapamide lowers blood pressure (BP) and preserves patients' metabolic profile better than all...
Calcium Channel Bockers : Yesterday, Today & Tomorrow Dr. Rajiv Karnik1 Oct 2021 2:32 PM ISTEvolution of Calcium Channel Blockers
Beta-blockers or amiodarone more effective than CCBs in AF patients in ICU: Study Dr. Shravani Dali27 July 2021 9:00 AM ISTBeta-blockers or amiodarone may be more beneficial as compared to the calcium channel blockers (CCBs) as first-line therapy in undifferentiated...
Nifedipine revisited: Extended-release formulations superior in patients with coronary artery disease, shows study Dr. Prem Aggarwal30 April 2021 12:45 PM ISTCoronary artery disease has been on a spiked rise owing to stressful lifestyles, coupled with unhealthy food choices and lack of regular exercise. The...
Combination Therapy in Hypertension with Diabetes: Preferential Consideration for CCB and ARBs Dr. Pramila Kalra4 Jan 2021 12:45 PM ISTThe last edition of the International Diabetes Federation (IDF) Atlas offered projections that continue to put India at the second slot in the...
Hypertension in Diabetes: Considering Therapies which Optimise Kidney Protection Dr Sujoy Ghosh20 Nov 2020 11:25 AM ISTHypertension and Diabetes remain the top two causes of End-Stage Renal Disease (ESRD) (1). Hence, it seems clinically appropriate to establish that...
Effective BP control: High dose ARB monotherapy or combination therapy of ARB and CCB for hypertension? Dr. Prem Aggarwal10 Oct 2020 10:30 AM ISTHypertension (HTN) is a global health hazard and a leading cause of mortality and morbidity. It is ranked third as a cause for disability-adjusted...
Nifedipine, Amlodipine linked to lower mortality, intubation in COVID-19 patients: Study Dr. Kamal Kant Kohli19 Aug 2020 12:18 PM ISTCOVID-19 pandemic continues to affect people worldwide with confirmed cases in more than 200 countries. As per recent reports, over 20+ million people...
Amlodipine and Cardiovascular outcomes in Hypertensive patients: What Meta-analysis says Dr. Prem Aggarwal17 Aug 2020 12:30 PM ISTA major risk factor for cardiovascular disease is hypertension. A multitude of drugs, including calcium channel blockers (CCBs), β-blockers,...
Amlodipine - A first-line agent in Hypertension Dr. Prem Aggarwal23 July 2020 10:45 AM ISTHypertension is a global health hazard and a leading cause of mortality and morbidity across the world. It is ranked third as a cause for...
Combination therapy for Hypertension: Olmesartan plus Azelnidipine or Olmesartan plus Amlodipine? Dr. Prem Aggarwal14 July 2020 12:45 PM ISTThe Protocol of Controlling Blood pressure (BP) in Hypertensive Patients is different in different parts of the world. Achieving adequate blood...
